rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Antoni Ribas

Director

Company insider

Files Form 4 as: Director, Arcus Biosciences.

In numbers

Trades disclosed
21
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
28 Oct 2019
Last trade
11 Jun 2026
Last filed
12 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
RCUS Arcus BiosciencesDirector · Biotechnology · last 11 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
11 Jun 2026filed 12 Jun 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Code A—5,700 at $0.00filing
11 Jun 2026filed 12 Jun 2026RCUS Arcus Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—16,900 at $0.00filing
11 Jun 2026filed 12 Jun 2026RCUS Arcus Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—16,900 at $0.00filing
11 Jun 2026filed 12 Jun 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Code A—5,700 at $0.00filing
16 Dec 2025filed 12 May 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Code G—5,050 at $0.00filing
16 Dec 2025filed 12 May 2026RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Code G—5,050 at $0.00filing
10 Jun 2025filed 12 Jun 2025RCUS Arcus Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—38,300 at $0.00filing
10 Jun 2025filed 12 Jun 2025RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Code A—13,300 at $0.00filing
23 Jan 2025filed 27 Jan 2025RCUS Arcus Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
6 Jun 2024filed 7 Jun 2024RCUS Arcus Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—24,000 at $0.00filing
6 Jun 2024filed 7 Jun 2024RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Code A—8,400 at $0.00filing
15 Jun 2023filed 16 Jun 2023RCUS Arcus Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—19,500 at $0.00filing
15 Jun 2023filed 16 Jun 2023RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Code A—6,800 at $0.00filing
14 Jun 2022filed 16 Jun 2022RCUS Arcus Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—16,800 at $0.00filing
14 Jun 2022filed 16 Jun 2022RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Code A—4,100 at $0.00filing
3 Jun 2021filed 7 Jun 2021RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Code A—3,000 at $0.00filing
3 Jun 2021filed 7 Jun 2021RCUS Arcus Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—14,100 at $0.00filing
4 Jun 2020filed 8 Jun 2020RCUS Arcus Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—14,000 at $0.00filing
4 Jun 2020filed 8 Jun 2020RCUS Arcus BiosciencesBiotechnologySEC FORM 4 Code A—3,000 at $0.00filing
17 Jan 2020filed 22 Jan 2020RCUS Arcus Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Alexander AzoyChief Accounting Officer · Chief Accounting Officer at Arcus Biosciences, filing Form 4 there in the last year
Juan C. JaenPresident · President at Arcus Biosciences, filing Form 4 there in the last year
Kathryn E. FalbergDirector · Director at Arcus Biosciences, filing Form 4 there in the last year
Yasunori KanekoDirector · Director at Arcus Biosciences, filing Form 4 there in the last year
Patrick MachadoDirector · Director at Arcus Biosciences, filing Form 4 there in the last year